HMGCR and Parkinson disease: From a clinical perspective, the identification of HMGCR variants may help define PD subtypes with metabolic comorbidities and guide the development of targeted, metabolism-informed therapeutic strategies, offering a pathway toward more personalized interventions in PD and related disorders.